April 21, 2026

Another State PBM Ban on Pharmacies Invites Headline Noise – and Ultimately Legal Challenges [CVS, CI, UNH]

By Beth Steindecker

While the passage of another ban on PBM ownership of pharmacies – this time in Tennessee – could reignite some headline risk for CVS, CI, and UNH, we think the actual risk of it going…

Read More >>

April 21, 2026

Being Coy on BALANCE – How Could CMS and Insurers Get to Yes [UNH, ELV, HUM, CVS, CNC, CI, MOH]

By Beth Steindecker

UnitedHealth’s (UNH) comments on its earnings call this morning, responding to a question about potential participation in CMS’s BALANCE obesity drug model, suggest that further design changes will be required for it – and likely…

Read More >>

April 21, 2026

INSP: MAC Modifier Feedback Bolsters View

By John Leppard

Amid persistent investor questions on Medicare Administrative Contractor (MAC) billing / coding requirements for Inspire Medical’s (INSP) Inspire V device, we continue to believe that the MACs will ultimately instruct providers to use the -52…

Read More >>

April 20, 2026

Capitol Policy Weekly: Reconciliation, Warsh, Export Controls, California Social Media in Focus

By Joe Lieber

With the House and Senate both in session this week, Washington’s focus will remain concentrated on the Iran-U.S. conflict, which heated up yesterday after the U.S. seized an Iranian ship. We have though an escalation…

Read More >>

April 17, 2026

(META, GOOGL, SNAP, TikTok) California’s Bipartisan Push to Ban Under-16s from Social Media Clears First Hurdle

By Joe Lieber

We assign roughly 65% probability that California’s pending legislation, AB 1709, which is a bipartisan ban on kids under 16 years old from creating accounts on social media platforms (META, GOOGL, SNAP, TikTok) that have…

Read More >>

April 15, 2026

Reconciliation 2.0: Defense and Healthcare in Focus

By Joe Lieber

Congressional Republicans seem poised to move ahead with a “skinny” $65-$75 billion reconciliation bill that, importantly for investors, does not look like it will include: The ~$200 billion in additional defense funds, in part to…

Read More >>

April 13, 2026

Capitol Policy Weekly: Iran, Powell, Trade, and DHS Funding Top the Agenda as Congress Returns

By Joe Lieber

With the House and Senate back in session this week after a two-week spring break, Washington’s focus will remain concentrated on the following issues:  The U.S.-Iran conflict and likely War Powers Resolution votes in both chambers.   The path for ~$200 billion in additional defense funding, $15-$25 billion in aid for farmers,…

Read More >>

April 12, 2026

Inpatient Hospitals: Slight Medicare Growth for FY27, But Future Holds Mandatory Bundles and Less Automatic Bonuses for New Tech [HCA, THC, CYH, ENSG, PACS, PNTG]

By Beth Steindecker

FY27 Medicare reimbursement proposals for inpatient hospitals [HCA, THC, CYH, ARDT, UHS, MPT, muni-backed systems] largely met expectations for a smaller increase, versus FY26, with most changes appearing formulaic and math-based rather than policy-led. Despite…

Read More >>

April 10, 2026

(ASML, TOELY, NVDA) New Semiconductor Export-Control Bill, the MATCH Act, Unlikely to Become Law

By Joe Lieber

In the past week, the House and Senate have introduced bipartisan legislation known as the MATCH Act, or the Multilateral Alignment of Technology Controls on Hardware Act, which poses headline risk for ASML (ASML) and Tokyo Electron (TOELY). The legislative measure is designed to tighten U.S. export controls on semiconductor manufacturing equipment…

Read More >>

April 9, 2026

Social Media Litigation and META/GOOGL Potential Valuations

By Joe Lieber

The recent social media verdicts in New Mexico and California raise the valuation question for investors about how far P/Es might fall for META (META) and (Alphabet) GOOGL assuming litigation risks continue and potentially intensifies. History’s answer is that the path isn’t linear. In different cases, it took the market time…

Read More >>

April 9, 2026

Inspire Medical (INSP): More MAC Wrinkles

By John Leppard

While we view today’s update of Medicare Administrative Contractor (MAC) WPS’s billing and coding article for hypoglossal nerve stimulation (HGNS) – omitting requirements that physicians bill using a -52 (reduced work) modifier – as directionally…

Read More >>

April 9, 2026

iRhythm (IRTC): Medicare Coverage Risks

By John Leppard

We estimate that iRhythm (IRTC) faces a 1%-2% growth headwind from a finalized local coverage determination (LCD) on ambulatory cardiac monitoring (ACM), likely to be released in the coming weeks. While we expect the company’s…

Read More >>

April 8, 2026

Quarterly Policy Catalysts 2Q26: Health Insurers & Providers

By Beth Steindecker

With government policy in flux and CY/FY27 payment updates coming into focus, we outline key 2Q potential policy catalysts and debates for health insurers and providers. While CMS’s improved CY27 Medicare Advantage rates offer a…

Read More >>

April 7, 2026

Conference Call Takeaways: (META, GOOGL) Meta and Google and the Risk of Addictive Design and Child Safety Verdicts

By Joe Lieber

We had the following takeaways from last week’s conference call we hosted on the recent verdicts in the META and GOOGL trials in New Mexico and California with two lawyers who are very familiar with similar Internet cases. A transcript or audio recording of the call is available…

Read More >>

April 6, 2026

Medicare Advantage: CY27 Final Rates Provide Expected Relief, Longer-Term Risks Punted or Persist [HUM, ALHC, UNH, CVS, ELV, CNC, PRVA, ASTH, EVH]

By Beth Steindecker

The final CY27 Medicare Advantage (MA) rate announcement, reflecting a net 2.48% YoY benchmark increase, landed within our expectations and alleviates some of the near term-pressure on MA insurers [HUM, ALHC, UNH, CVS, ELV, CNC]…

Read More >>